Xponential Fitness (XPOF) Q2 Earnings Surpass Estimates

Xponential Fitness (XPOF) reported Q2 earnings of $0.26 per share, significantly exceeding the Zacks Consensus Estimate of $0.19 and marking a turnaround from a year-ago loss. However, revenues for the quarter ended June 2025 totaled $76.21 million, missing consensus by 1.23% and slightly declining year-over-year. Despite the EPS beat, the company has only surpassed consensus EPS once in the past four quarters, and its shares have underperformed, down 23.3% year-to-date against the S&P 500's gain. The stock carries a Zacks Rank #4 (Sell) due to unfavorable estimate revisions and operates within a low-ranked industry, suggesting potential near-term underperformance.

Analysis

Xponential Fitness (XPOF) reported a mixed second quarter, highlighted by a significant earnings beat with an adjusted EPS of $0.26, surpassing the consensus estimate of $0.19 and reversing a prior-year loss. However, this bottom-line strength was undermined by top-line weakness, as revenues of $76.21 million missed forecasts by 1.23% and declined slightly from the year-ago figure of $76.52 million. The positive earnings surprise is an outlier, representing the company's only EPS beat in the last four quarters and following a severe -233.33% miss in the preceding quarter. This inconsistent performance is set against a backdrop of significant stock underperformance, with shares down 23.3% year-to-date. Compounding the bearish case, the stock carries a Zacks Rank #4 (Sell) due to an unfavorable trend in earnings estimate revisions, and its Leisure and Recreation Services industry is ranked in the bottom 26%, suggesting potential for continued market underperformance.

Key Decisions for Investors

• Investors should treat the strong EPS beat with caution, given that it was accompanied by a revenue miss, a slight year-over-year revenue decline, and a poor track record of earnings consistency over the past year.
• Closely monitor management's forward-looking commentary from the earnings call and subsequent analyst estimate revisions, as these factors will be critical in determining if the current Zacks #4 (Sell) rank and bearish outlook will change.
• Acknowledge the significant risk factors, including the stock's 23.3% year-to-date decline and the underperformance of its industry, which may continue to act as headwinds against share price appreciation.